Sure, there are reasons for optimism. But there may be too many risks to justify jumping into U.S. stocks at these levels.

Eli Lilly (NYSE:LLY) is a pharmaceutical titan with an $815 billion market cap, putting it on track to be the next $1 ...

Len Yaffe, Kessef Capital Management, joins 'Fast Money' to talk opportunities in the pharma stock space. Trump blames ...

Trump's tariffs continue to affect markets. Follow along for Live updates on stocks and other markets, including the Dow Jones Industrial Average, S&P 500 and Nasdaq Composite.

Growth stocks have taken a hit in the market so far this year as investors have entered risk-off mode, thanks to the economic ...

The U.S. Securities and Exchange Commission (SEC) has approved sweeping changes to the Nasdaq Capital Market listing ...

The AI boom in 2025 is driving strong demand for Broadcom's AI infrastructure solutions, making it a compelling buy despite ...

The U.S. and China are at least talking about talking about tariffs, and investors, traders and speculators are showing a ...

Akeso has shared for the first time overall survival data from a high-profile Keytruda head-to-head trial for its PD-1xVEGF ...

Despite a $645,000 year-over-year price drop, this enclave outpaced all competitors, driven by high-end condominium sales and ...

Trading occurs Monday through Friday, with the opening bell ringing at 9:30 a.m., Eastern Time, and the closing bell marking ...

Earlier this month, Democrats sounded the alarm on concerns that Trump or those around him engaged in insider trading after ...